Risk assessment of p53 genotypes and hap
β
Sayan Mitra; Nilabja Sikdar; Chaitali Misra; Shalini Gupta; Ranjan Rashmi Paul;
π
Article
π
2005
π
John Wiley and Sons
π
French
β 114 KB
## Abstract The role of 3 __p53__ polymorphisms (16 bp duplication at intron 3, codon 72 Arg/Pro and intron 6 __Nci__I RFLP at np 13494) as potential markers for indicating cancer risk remains inconclusive. In our caseβcontrol study consisting of 197 leukoplakia and 310 oral squamous cell carcinoma